Apyx Medical Inc

NASDAQ APYX

Data sourced from

and

Download Data

Apyx Medical Inc Cash Flow Coverage Ratio 5 year CAGR for the year ending December 31, 2023: -43.83%

Apyx Medical Inc Cash Flow Coverage Ratio 5 year CAGR is -43.83% for the year ending December 31, 2023, a -138.54% change year over year. The cash flow coverage ratio evaluates a company's ability to cover its interest expense with its operating cash flow after deducting capital expenditures. It is calculated by dividing the difference between operating cash flow and capital expenditures by interest expense. This ratio indicates the company's ability to generate enough cash flow to service its interest payments. A higher ratio signifies better coverage and financial stability. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.

Apyx Medical Inc Cash Flow Coverage Ratio for the year ending December 31, 2022 was -1,419.33, a -27.04% change year over year.
Apyx Medical Inc Cash Flow Coverage Ratio for the year ending December 31, 2021 was -1,117.20, a -208.71% change year over year.
Apyx Medical Inc Cash Flow Coverage Ratio for the year ending December 31, 2020 was -361.89, a 85.36% change year over year.
Apyx Medical Inc Cash Flow Coverage Ratio for the year ending December 31, 2019 was -2,472.00, a -5,821.51% change year over year.

NASDAQ: APYX

Apyx Medical Inc

CEO	Mr. Charles D. Goodwin II
IPO Date	Jan. 1, 1987
Location	United States
Headquarters	5115 Ulmerton Road, Clearwater, FL, United States, 33760
Employees	252
Sector	Healthcare
Industry	Medical devices

Description

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Key trends